|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Cervical Cancer | |||||
| Genital Warts | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Carcinoma in Situ | |||||
| Cervical Intraepithelial Neoplasia | |||||
| Condylomata Acuminata | |||||
| Uterine Cervical Neoplasms | |||||
| Warts | |||||
| 3 | More general conditions related to this trial | ||||
| Carcinoma | |||||
| DNA Virus Infections | |||||
| Genital Diseases, Female | |||||
| Genital Neoplasms, Female | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| Neoplasms by Site | |||||
| Neoplasms, Glandular and Epithelial | |||||
| Papillomavirus Infections | |||||
| Sexually Transmitted Diseases | |||||
| Sexually Transmitted Diseases, Viral | |||||
| Skin Diseases | |||||
| Skin Diseases, Infectious | |||||
| Skin Diseases, Viral | |||||
| Tumor Virus Infections | |||||
| Urogenital Neoplasms | |||||
| Uterine Cervical Diseases | |||||
| Uterine Diseases | |||||
| Uterine Neoplasms | |||||
| Virus Diseases | |||||
| 4 | Sponsors listed in this trial | ||||
| Merck | |||||